CoChat

Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer

Open access

The DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Diabetic men have lowered overall risk of prostate cancer (PCa), but the role of hyperglycaemia is unclear. In this cohort study, we estimated PCa risk among men with diabetic fasting blood glucose level. METHODS: Participants of the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC) were linked to laboratory database for information on glucose measurements since 1978. The data were available for 17,860 men. Based on the average yearly level, the men were categorised as normoglycaemic, prediabetic, or diabetic. Median follow-up was 14.7 years. Multivariable-adjusted Cox regression was used to calculate hazard ratios (HRs) and 95% confidence intervals (95% CIs) for prostate cancer overall and separately by Gleason grade and metastatic stage. RESULTS: In total 1,663 PCa cases were diagnosed. Compared to normoglycaemic men, those men with diabetic blood glucose level had increased risk of PCa (HR 1.52; 95% CI 1.31-1.75). The risk increase was observed for all tumour grades, and persisted for a decade afterwards. Antidiabetic drug use removed the risk association. Limitations include absence of information on lifestyle factors and limited information on BMI. CONCLUSIONS: Untreated diabetic fasting blood glucose level may be a prostate cancer risk factor.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-018-0055-4

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Association between overall prostate cancer risk and blood glucose level in subgroup analysis. Study cohort of 17,860 men from the Finnish Randomized Study of Screening for Prostate Cancer. Pre-D pre-diabetic, D diabetic blood glucose level. *P for interaction = 0.229 for pre-diabetic, p < 0.001 for diabetic men. **P for interaction = 0.435 for pre-diabetic, p = 0.018 for diabetic men. ***P for interaction = 0.153 for pre-diabetic, p < 0.001 for diabetic men. NSAID non-steroidal anti-inflammatory drugs, ASA acetylsalicylic acid
Fig. 1 Association between overall prostate cancer risk and blood glucose level in subgroup analysis. Study cohort of 17,860 men from the Finnish Randomized Study of Screening for Prostate Cancer. Pre-D pre-diabetic, D diabetic blood glucose level. *P for interaction = 0.229 for pre-diabetic, p < 0.001 for diabetic men. **P for interaction = 0.435 for pre-diabetic, p = 0.018 for diabetic men. ***P for interaction = 0.153 for pre-diabetic, p < 0.001 for diabetic men. NSAID non-steroidal anti-inflammatory drugs, ASA acetylsalicylic acidCC BY · PubMed Central
Fig. 2 Association between Gleason 8–10 prostate cancer risk and blood glucose level in subgroup analysis. Study cohort of 17,860 men from the Finnish Randomized Study of Screening for Prostate Cancer. Pre-D pre-diabetic, D diabetic blood glucose level. NSAID non-steroidal anti-inflammatory drugs, ASA acetylsalicylic acid
Fig. 2 Association between Gleason 8–10 prostate cancer risk and blood glucose level in subgroup analysis. Study cohort of 17,860 men from the Finnish Randomized Study of Screening for Prostate Cancer. Pre-D pre-diabetic, D diabetic blood glucose level. NSAID non-steroidal anti-inflammatory drugs, ASA acetylsalicylic acidCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Cited by

See all 28

Metadata

Authors
Murtola, T. J., Vihervuori, V. J., Lahtela, J., Talala, K., Taari, K., Tammela, T. L., & Auvinen, A.
Affiliations
  • Tampere University (FI)
  • Tampere University Hospital (FI)
  • Finnish Cancer Registry (FI)
  • Helsinki University Hospital (FI)
  • University of Tampere (FI)
Corresponding author
Murtola, Teemu J.
Venue
British Journal of Cancer
Published
2018-03-22
Volume
118
Issue
9
Pages
1248-1254
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2792056645
Cited by
28
References
31
Citations by year
2026: 2 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 5 · 2021: 4 · 2020: 4 · 2019: 2
FWCI
0.89
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Tampere University Institutional Repository (Tampere University) (acceptedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion, other-oa)
  • Tampere University Institutional Repository (Tampere University) (submittedVersion)
Funders
Pirkanmaan Sairaanhoitopiiri (150640)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer Risks and Factors
Keywords
prostate cancer, fasting blood glucose, hyperglycemia, diabetes mellitus, glycemic control, prediabetes, prostate cancer risk factors, Gleason grade, metastatic prostate cancer, antidiabetic drug use
MeSH terms
Aged, Blood Glucose, Diabetes Mellitus, Type 2, Fasting, Finland, Humans, Hyperglycemia, Hypoglycemic Agents, Male, Mass Screening, Middle Aged, Prostatic Neoplasms, Registries, Risk Factors, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. https://app.cochat.ai/papers/10.1038/s41416-018-0055-4
The paper
Murtola, T. J., Vihervuori, V. J., Lahtela, J., Talala, K., Taari, K., Tammela, T. L., & Auvinen, A. (2018). Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. British Journal of Cancer. https://doi.org/10.1038/s41416-018-0055-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.